Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSPFERREIRA, Karine A.TEIXEIRA, Manoel JacobsenMENDONZA, Tito R.CLEELAND, Charles S.2017-11-272017-11-272011SUPPORTIVE CARE IN CANCER, v.19, n.4, p.505-511, 20110941-4355https://observatorio.fm.usp.br/handle/OPI/23126To validate the Brazilian version of the Brief Pain Inventory (BPI-B) scale and to determine the optimal cutpoints for mild, moderate, and severe pain based on patients' rating of their worst pain. One hundred forty-three outpatients with cancer were recruited in Hospital das Clinicas-University of Sao Paulo, Brazil. Confirmatory factor analysis confirmed two underlying dimensions, pain severity, and pain interference, with Cronbach's alpha of 0.91 and 0.87, respectively. Convergent validity was shown by the correlation observed between the BPI dimensions with the EORTC-QLQ-C30 pain scale and the McGill Pain Questionnaire. The BPI-B detected significant differences in the two dimensions by disease and performance status, supporting known-group validity. For the worst pain, the optimal cutpoints were 4 and 7 (1-4 = mild pain, 5-7 = moderate, and 8-10 = severe). Our data show that BPI-B is a brief, useful, and valid tool for assessing pain and its impact on patient's life.engrestrictedAccessNeoplasmPainPain measurementReproducibility of resultsValidation studiescancer painclinical-trialsversioncutpointsseverityutilityquestionnaireestablishmentexplorationmoderatearticleCopyright SPRINGER10.1007/s00520-010-0844-7OncologyHealth Care Sciences & ServicesRehabilitation1433-7339